Literature DB >> 20523351

Liver: diuretic agents for ascites: joining forces from the start?

Pere Ginès1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20523351     DOI： 10.1038/nrgastro.2010.63

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  5 in total

1.  Guidelines on the management of ascites in cirrhosis.

Authors:  K P Moore; G P Aithal
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

2.  Management of adult patients with ascites due to cirrhosis: an update.

Authors:  Bruce A Runyon
Journal:  Hepatology       Date:  2009-06       Impact factor: 17.425

3.  Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial.

Authors:  P Angeli; S Fasolato; E Mazza; L Okolicsanyi; G Maresio; E Velo; A Galioto; F Salinas; M D'Aquino; A Sticca; A Gatta
Journal:  Gut       Date:  2010-01       Impact factor: 23.059

Review 4.  Management and treatment of patients with cirrhosis and portal hypertension: recommendations from the Department of Veterans Affairs Hepatitis C Resource Center Program and the National Hepatitis C Program.

Authors:  Guadalupe Garcia-Tsao; Joseph K Lim; Joseph Lim
Journal:  Am J Gastroenterol       Date:  2009-05-19       Impact factor: 10.864

5.  Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety.

Authors:  Justiniano Santos; Ramon Planas; Albert Pardo; Rosa Durández; Eduard Cabré; Rosa Maria Morillas; Maria Luisa Granada; José Angel Jiménez; Enrique Quintero; Miquel Angel Gassull
Journal:  J Hepatol       Date:  2003-08       Impact factor: 25.083
  5 in total
  1 in total

1.  Colonic Delivery of Celastrol-Loaded Layer-by-Layer Liposomes with Pectin/Trimethylated Chitosan Coating to Enhance Its Anti-Ulcerative Colitis Effects.

Authors:  Jing Xian; Xuemei Zhong; Huan Gu; Xiao Wang; Jiaxin Li; Jingjing Li; Yihan Wu; Chen Zhang; Jinming Zhang
Journal:  Pharmaceutics       Date:  2021-11-25       Impact factor: 6.321
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.